Zobrazeno 1 - 10
of 286
pro vyhledávání: '"59"'
Autor:
Keisuke Hata, Kazuhito Sasaki, Keiichi Arakawa, Hiroaki Nozawa, Masaya Hiyoshi, Satoshi Okada, Hirofumi Sonoda, Kazushige Kawai, Yasutaka Shuno, Toshiaki Tanaka, Manabu Kaneko, Koji Murono, Takeshi Nishikawa, Shigenobu Emoto, Soichiro Ishihara
Publikováno v:
Anticancer research. 39(3)
Background We aimed to investigate the molecular features of synchronous colorectal cancer (CRC). Materials and methods Out of 1,262 patients with CRC, 130 lesions in 59 patients with synchronous CRC were retrospectively analyzed. Microsatellite, v-K
Autor:
A. Bardelli
Publikováno v:
European Journal of Cancer Supplements. 7:17
Autor:
Luciana Kikuchi, Alice M. Isejima, Paulo M. Hoff, Marcelo Queiroz, Leonardo Gomes da Fonseca, Maria Ignez Braghiroli, Joao Glasberg, Christian Kappeler, Luiz Antonio Senna Leite, Daniela R. Nebuloni, Giovanni M. Bariani, Rachel P. Riechelmann, Thomas Giollo Rivelli
Publikováno v:
The Oncologist. 24:1180-1187
Background Regorafenib is a multikinase inhibitor with antiangiogenic effects that improves overall survival (OS) in metastatic colorectal cancer (mCRC) after failure of standard therapies. We investigated the efficacy and safety of regorafenib in an
Autor:
Scott M. Lippman, Ryosuke Okamura, Razelle Kurzrock, Paul T. Fanta, Lawrence Leichman, In Sil Choi, Richard B. Lanman, Victoria M. Raymond, Shumei Kato
Publikováno v:
Molecular cancer therapeutics, vol 18, iss 10
Molecular profiling of circulating tumor DNA (ctDNA) is a promising noninvasive tool. Here, next-generation sequencing (NGS) of blood-derived ctDNA was performed in patients with advanced colorectal cancer. We investigated ctDNA-derived genomic alter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290193aa9ced4e27403ae647b2879efc
https://escholarship.org/uc/item/0mj0j211
https://escholarship.org/uc/item/0mj0j211
Publikováno v:
Journal of Clinical Oncology. 38:59-59
59 Background: This study was aimed at measuring the preventive effect of colonoscopy for CRC development depending on age of index colonoscopy, gender and metabolic syndrome among persons aged 40 to 59 years. Methods: Between January 2005 and Decemb
Autor:
Gauri R. Varadhachary, Priya Bhosale, Vivek Subbiah, Scott Kopetz, Madhavi Patnana, Michael J. Overman, Christine Megerdichian Parseghian, Milind Javle, Shubham Pant, Aung Naing, Ya Chen Tina Shih, Hung Le, Kenneth R. Hess, David S. Hong, Bumyang Kim, Sarina Anne Piha-Paul
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 41(6)
Pseudoprogression has been observed in patients with various tumor types treated with immunotherapy. However, the frequency of pseudoprogression is unknown in gastrointestinal malignancies. Metastatic colorectal cancer (mCRC) and advanced pancreatic
Autor:
R. Bryan Rumble, Nancy Roach, Pamela B. Mangu, Richard L. Schilsky, Carmen J. Allegra, Alexander Hantel, Stanley R. Hamilton
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(2)
Purpose An American Society of Clinical Oncology Provisional Clinical Opinion (PCO) offers timely clinical direction after publication or presentation of potentially practice-changing data from major studies. This PCO update addresses the utility of
Autor:
Jose Carlos Martinez Avila, Jair Tenorio, Hoi Tong, Lorena Ostios, Nuria Rodriguez Salas, Alberto M. Borobia, María Teresa García Morales, Jesus Miranda, Mario Muñoz, Gema Gordo
Publikováno v:
Journal of Clinical Oncology. 36:718-718
718 Background: mCRC is the 2º cause of death in the world. Development of targeted therapies has increased the survival. The efficacy of these drugs (such Bevacizumab and monoclonal antibodies against EGFR) depends on the use of genetic biomarkers
Autor:
Benekli, Mustafa, Dumanli, Esra, Kilickap, Saadettin, Uncu, Dogan, Aliustaoglu, Mehmet, Cicin, Irfan, Gumus, Mahmut, Ozkan, Metin, Kocer, Murat, Karaoglu, Aziz, Dane, Faysal, Isikdogan, Abdurrahman, Elkiran, Tamer, Yalcin, Bulent, Uysal, Mukremin, Oksuzoglu, Berna, Boruban, Melih Cem, Ulas, Arife, Abali, Huseyin, Buyukberber, Suleyman, Tekin, Salim Basol, Avci, Nilufer, Sevinc, Alper, Ozdemir, Feyyaz, Ruchan Uslu, Turna, Hande, Ozturk, Banu, Kara, Oguz, Kaya, Ali Osman
Publikováno v:
ResearcherID
e12646 Background: Colorectal cancers (CRC) have become the 3rd most common cancer in Turkey with increasing incidence over the years. Studies investigating the clinical and biologic features of CRC Turkey are small retrospective case series providin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8085e848af63b12703c517131411b3b
https://avesis.gazi.edu.tr/publication/details/ce4d1b69-4927-468e-8c4b-2b13ac77e693/oai
https://avesis.gazi.edu.tr/publication/details/ce4d1b69-4927-468e-8c4b-2b13ac77e693/oai
Autor:
Praveena Iruku, Stephanie Purkat Lindauer, Sherri Rauenzahn, Jessica Trevino Jones, Brandon Konkel, Sukeshi R. Patel, Kinan Yarta, Andrew McCracken, Annie Hung, Matthew James Butler, Tamna Wangjam
Publikováno v:
Journal of Clinical Oncology. 35:e18233-e18233
e18233 Background: Timeliness of cancer treatment is an important aspect of health care quality. Colorectal cancer (CRC) care requires the coordinated multidisciplinary effort of various aspects of the health care system, which can lead to delays bet